These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21989433)

  • 1. Use of metronomic chemotherapy in oncology: results from a national Italian survey.
    Collovà E; Sebastiani F; De Matteis E; Generali D; Aurilio G; Boccardo F; Crispino S; Cruciani G
    Tumori; 2011; 97(4):454-8. PubMed ID: 21989433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.
    Saridaki Z; Malamos N; Kourakos P; Polyzos A; Ardavanis A; Androulakis N; Kalbakis K; Vamvakas L; Georgoulias V; Mavroudis D
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):35-42. PubMed ID: 21590447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Lunardi G; Venturini M;
    Tumori; 2013; 99(1):35-8. PubMed ID: 23548997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic chemotherapy in metastatic breast cancer: impact on VEGF.
    El-Arab LR; Swellam M; El Mahdy MM
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):15-22. PubMed ID: 23587228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On and off metronomic oral vinorelbine in elderly women with advanced breast cancer.
    De Iuliis F; Salerno G; Taglieri L; Lanza R; Scarpa S
    Tumori; 2015; 101(1):30-5. PubMed ID: 25702645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG).
    Biganzoli L; Goldhirsch A; Straehle C; Castiglione-Gertsch M; Therasse P; Aapro M; Minisini A; Piccart MJ;
    Ann Oncol; 2004 Feb; 15(2):207-10. PubMed ID: 14760110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomics chemotherapy: time for computational decision support.
    Barbolosi D; Ciccolini J; Meille C; Elharrar X; Faivre C; Lacarelle B; André N; Barlesi F
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):647-52. PubMed ID: 25082520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)".
    Di Genesio Pagliuca M; Turri L; Munoz F; Melano A; Bacigalupo A; Franzone P; Sciacero P; Tseroni V; Vitali ML; Delmastro E; Scolaro T; Marziano C; Orsatti M; Tessa M; Rossi A; Ballare A; Moro G; Grasso R; Krengli M
    Tumori; 2013; 99(1):61-7. PubMed ID: 23549002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.
    Montagna E; Palazzo A; Maisonneuve P; Cancello G; Iorfida M; Sciandivasci A; Esposito A; Cardillo A; Mazza M; Munzone E; Lai A; Goldhirsch A; Colleoni M
    Cancer Lett; 2017 Aug; 400():276-281. PubMed ID: 28131905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
    Sanna G; Pestrin M; Moretti E; Biagioni C; De Santo I; Gabellini S; Galardi F; McCartney A; Biganzoli L
    Clin Breast Cancer; 2021 Aug; 21(4):e332-e339. PubMed ID: 33353853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronomic chemotherapy against cancer: from paradigm to clinical practice?
    Calvani N; Orlando L; Nacci A; Sponziello F; Cinefra M; Cinieri S
    Tumori; 2009; 95(6):843-5. PubMed ID: 20210257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.
    Cox MC; Banchi M; Pelliccia S; Di Napoli A; Marcheselli L; Patti C; Anticoli Borza P; Battistini R; Di Gregorio F; Orlandi P; Bocci G
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):841-846. PubMed ID: 33070248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.
    Lorusso V; Crucitta E; Silvestris N; Guida M; Misino A; Latorre A; De Lena M
    Clin Breast Cancer; 2003 Jun; 4(2):138-41. PubMed ID: 12864942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.
    Montagna E; Cancello G; Bagnardi V; Pastrello D; Dellapasqua S; Perri G; Viale G; Veronesi P; Luini A; Intra M; Calleri A; Rampinelli C; Goldhirsch A; Bertolini F; Colleoni M
    Clin Breast Cancer; 2012 Jun; 12(3):207-14. PubMed ID: 22520733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer.
    Shi H; Jiang J; Ji J; Shi M; Cai Q; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
    Cancer Lett; 2014 Jul; 349(2):128-35. PubMed ID: 24746899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists.
    Revon-Rivière G; Banavali S; Heississen L; Gomez Garcia W; Abdolkarimi B; Vaithilingum M; Li CK; Leung PC; Malik P; Pasquier E; Epelman S; Chantada G; André N
    J Glob Oncol; 2019 Jul; 5():1-8. PubMed ID: 31260397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.
    Briasoulis E; Aravantinos G; Kouvatseas G; Pappas P; Biziota E; Sainis I; Makatsoris T; Varthalitis I; Xanthakis I; Vassias A; Klouvas G; Boukovinas I; Fountzilas G; Syrigos KN; Kalofonos H; Samantas E
    BMC Cancer; 2013 May; 13():263. PubMed ID: 23718900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.
    Nolè F; Catania C; Sanna G; Imadalou K; Munzone E; Adamoli L; Longerey B; Blanchot G; Goldhirsch A
    Ann Oncol; 2006 Feb; 17(2):322-9. PubMed ID: 16303864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic chemotherapy for advanced breast cancer patients.
    Cazzaniga ME; Dionisio MR; Riva F
    Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes.
    Kellokumpu-Lehtinen PL; Sunela K; Lehtinen I; Joensuu H; Sjöström-Mattson J;
    Clin Breast Cancer; 2006 Dec; 7(5):401-5. PubMed ID: 17239265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.